While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

Last month, Purdue Pharma filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, after the ...

Vincerx Pharma, Inc. announced that it intends to voluntarily delist its common stock from Nasdaq after receiving a notice of non-compliance due to the stock's closing bid price falling below the ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term ... that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter ...

The stock was up a further 5% in recent trading and was among the top gainers in the S&P 500. Shares have added nearly 30% of their value in 2025 and have skyrocketed 345% over the past 12 months.

Ericsson shares surged Tuesday after the company reported first-quarter profit that topped analysts’ expectations. The Swedish company said North American sales jumped due to “accelerated ...

Currently, Ascendis Pharma has a market capitalization of $9.32 billion. Buying $1000 In ASND: If an investor had bought $1000 of ASND stock 10 years ago, it would be worth $81,183.25 today based ...

About 30% of Big Pharma acquisitions involving at least $50 million upfront in 2024 involved Chinese corporations, according to DealForma statistics, as reported by CNBC. This was an increase from ...

Here’s something investors don’t see very often: The stock market and the U.S. dollar are retreating side by side, and history, while limited, suggests investors should stay on their toes.

Ironwood Pharmaceuticals (NASDAQ:IRWD) announced Monday it has decided to evaluate strategic alternatives for the company after the FDA required an additional Phase 3 trial to secure approval for ...